Evidence for ethnic differences in cancer drug metabolism and deposition: potential relevance for clinical trials and practice
- PMID: 21968438
- DOI: 10.1159/000331337
Evidence for ethnic differences in cancer drug metabolism and deposition: potential relevance for clinical trials and practice
Comment on
-
Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors.Oncology. 2011;81(2):65-72. doi: 10.1159/000331010. Epub 2011 Sep 30. Oncology. 2011. PMID: 21968463 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources